Entity Common Stock, Shares Outstanding of Monopar Therapeutics from 26 Mar 2018 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Monopar Therapeutics quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 26 Mar 2018 to 31 Oct 2025.
  • Monopar Therapeutics Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 6,682,584, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 6,682,584 +1,404,788 +27% 31 Oct 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 6,169,961 -11,431,866 -65% 31 Jul 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 6,112,593 -11,342,332 -65% 14 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 5,277,796 -9,588,604 -64% 31 Oct 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 17,601,827 +3,443,886 +24% 31 Jul 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 17,454,925 +4,261,753 +32% 08 Mar 2024 10-K 28 Mar 2024 2023 FY
Q3 2023 14,866,400 +2,010,665 +16% 07 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 14,157,941 +1,432,190 +11% 28 Jul 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 13,193,172 +588,658 +4.7% 10 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 12,855,735 +265,123 +2.1% 31 Oct 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 12,725,751 +143,023 +1.1% 29 Jul 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 12,604,514 +37,585 +0.3% 11 Mar 2022 10-K 24 Mar 2022 2021 FY
Q3 2021 12,590,612 +1,138,435 +9.9% 31 Oct 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 12,582,728 +1,846,332 +17% 31 Jul 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 12,566,929 +1,945,394 +18% 05 Mar 2021 10-K 25 Mar 2021 2020 FY
Q3 2020 11,452,177 +2,160,756 +23% 31 Oct 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 10,736,396 +1,444,975 +16% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 10,621,535 +1,330,114 +14% 13 Mar 2020 10-K 27 Mar 2020 2019 FY
Q3 2019 9,291,421 -0 0% 12 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 9,291,421 0 0% 09 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 9,291,421 -0 0% 25 Feb 2019 10-K 26 Feb 2019 2018 FY
Q3 2018 9,291,421 09 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 9,291,421 09 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 9,291,421 26 Mar 2018 10-K 26 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.